Skip to main content
RNA logo

RNA · Atrium Therapeutics, Inc. · Short Interest

Track RNA — free
$7.50 -0.46 (-5.78%) At close · Nov 12
Market Cap
$128.29M
Shares
21.57M
Volume · Nov 12 294.72K Avg daily vol (3M) 288.66K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

RNA Latest Reported Short Interest

FINRA reported 3,749,186 RNA shares sold short as of the October 30, 2026 settlement date, an increase of 22,884 shares. Days to cover was 16.07 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

RNA Short Interest Forecast

Equibles' model estimates 3,712,635 shares sold short for the November 13, 2026 settlement, -1.0% versus the latest reported position, with a likely range of 3,399,450 to 4,030,538 shares. This model prediction uses FINRA data through November 12, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 12 Low confidence 59% chance it falls
3,712,635 -1.0% vs reported
Likely range 3,399,450 to 4,030,538 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
63/100
Short interest 17.4% of shares — P97 Days to cover 16.1 — P96 Price vs VWAP -22.2% — P22 Short-volume trend -21.9% — P5 Short interest change +0.6% — P59 Worst FTD 0.01% of shares — P44

Positioning score 62.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No listed expiration after today falls within the next 30 calendar days.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-13 06:21 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-30 Scheduled
FINRA publishes Dec 9
— — — —
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 3,749,186 3,726,302 +22,884 16.07
2026-10-15 3,726,302 3,395,873 +330,429 12.94
2026-09-30 3,395,873 3,397,791 -1,918 8.27
2026-09-15 3,397,791 3,351,526 +46,265 8.15
2026-08-31 3,351,526 3,480,849 -129,323 19.79
2026-08-14 3,480,849 3,514,133 -33,284 27.46
2026-07-31 3,514,133 3,591,224 -77,091 28.39
2026-07-15 3,591,224 3,656,821 -65,597 17.71
2026-06-30 3,656,821 3,610,418 +46,403 12.52
2026-06-15 3,610,418 3,653,605 -43,187 20.31
2026-05-29 3,653,605 3,732,204 -78,599 15.83
2026-05-15 3,732,204 3,425,955 +306,249 21.18
2026-04-30 3,425,955 3,016,880 +409,075 8.71
2026-04-15 3,016,880 1,913,700 +1,103,180 6.00
2026-03-31 1,913,700 1,184,615 +729,085 2.90
2026-03-13 1,184,615 432,798 +751,817 1.00
2026-02-27 432,798 0 +432,798 1.00
2026-02-13 10,156,722 8,745,197 +1,411,525 3.56
2026-01-30 8,745,197 8,406,349 +338,848 6.35
2026-01-15 8,406,349 8,791,796 -385,447 4.20
2025-12-31 8,791,796 9,740,063 -948,267 4.61
2025-12-15 9,740,063 8,865,578 +874,485 4.12
2025-11-28 8,865,578 10,321,719 -1,456,141 3.31
2025-11-14 10,321,719 10,497,758 -176,039 2.03

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 2093101 CUSIP 04965N104 13F (30d) 61 filings 61 filers Visit website Investor relations